33,316 press releases indexed under finance.
STOCKHOLM, Oct. 2, 2026 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV) (SSE: ALIVsdb), the worldwide leader in automotive safety systems, has appointed Natalie Draisin and Thomas Manfred Müller to its Research Advisory Board. Bringing valuable expertise and new perspectives, they join a...
Multiple EAI robots showcased at IROS 2026 further highlight the Robotics Business's "One-Brain Multi-Form Multi-Capability" EAI Robot World 2.0, with All-New Futurist drawing most attention from attendees. The Company engaged with various attendees including developers and ecosystem...
Nasdaq Copenhagen Euronext Dublin London Stock Exchange Other stakeholders
Nasdaq Copenhagen Euronext Dublin London Stock Exchange Øvrige interessenter
The acquisition is Samfara's first investment and is backed by a syndicate of European and North American institutional investors and family offices LONDON, Oct. 2, 2026 /PRNewswire/ -- Samfara, a European life sciences investment firm, today announced that it has completed the...
BASEL, Switzerland, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Today Ultragenyx announced that the European Medicines Agency (EMA) has validated the Company's Marketing Authorisation Application (MAA) for its investigational gene therapy, rebisufligene etisparvovec, for the treatment of mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo syndrome Type A.
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / October 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ:AARD) securities. If you suffered a loss on your Aardvark Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Aardvark Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a class ..
Daytoon's Legend in Residence brings a ring-tested code of discipline to how its customers raise a glass. [PR.com]
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / October 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ:AARD) securities. If you suffered a loss on your Aardvark Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Aardvark Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a class ..
加利福尼亚州卡尔弗城, Oct. 02, 2026 (GLOBE NEWSWIRE) -- 全球领先的互动数字娱乐领域独立开发商与发行商 Snail, Inc. (Nasdaq: SNAL，以下简称 “Snail Games” 或 “公司”) ，今日宣布参与 2026 年 Steam 秋季特卖，旗下产品组合将于 2026 年 10 月 1 日至 10 月 8 日期间开启限时折扣。
加州卡爾弗城, Oct. 02, 2026 (GLOBE NEWSWIRE) -- 全球領先的獨立互動數碼娛樂開發商與發行商 Snail, Inc. (Nasdaq: SNAL) (下稱「Snail Games」或「公司」) 今日宣佈參與 2026 年 Steam 秋季特賣，將於 2026 年 10 月 1 日至 10 月 8 日期間，為旗下產品組合推出限時折扣。
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / October 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ:AARD) securities. If you suffered a loss on your Aardvark Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Aardvark Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a class ..